David Pepperl, a highly accomplished toxicology and pharmacology expert, is a Senior Consultant and Nonclinical Group Leader at Biologics Consulting, specializing in pre-clinical drug development. He is a staunch advocate for advancing medical research and development and has contributed significantly to the scientific community's growth.

David is an alumnus of the prestigious University of Arizona, where he completed his doctorate in Toxicology and Pharmacology. He also graduated with a Bachelor of Science in Biochemistry from Michigan State University.

David has held several significant positions in his illustrious career, including Manager of Preclinical Development roles at Gene Logic, Therimmune Research Corporation, and SRA Life Sciences. Prior to that, he was a postdoctoral fellow at Pfizer and Pharmacia Upjohn IT.

David is a seasoned professional in drug discovery and development, with experience in Phase I-III trials and indications spanning multiple therapeutic areas such as oncology, autoimmune diseases, and inflammatory conditions. He has published and presented his work at various conferences, demonstrates excellent leadership and communication skills, and is a reliable team player in collaborative environments.

Overall, David's impressive background exemplifies his proficiency in pre-clinical drug development, pharmacology, and toxicology, making him a valuable asset to any company or institution.